Open channel block of Kv1.3 by rosiglitazone and troglitazone: Kv1.3 as the pharmacological target for rosiglitazone

Author： Ahn Hye Kim Sung Jang Hyun-Jong Kim Myung-Jun Rhie Duck-Joo Yoon Shin-Hee Jo Yang-Hyeok Kim Myung-Suk Sung Ki-Wug Kim Seong Hahn Sang

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.374, Iss.4, 2007-01, pp. : 305-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 801-806

Bentham Science Publishers

Access to resources Recommend Favorite

Kv1.3 potassium channel blockade as an approach to insulin resistance

By Desir Gary V

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 571-579

Informa Healthcare

Access to resources Recommend Favorite

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840

By Wulff Heike

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1759-1765

Informa Healthcare

Access to resources Recommend Favorite

Kv1.3 potassium channels as a therapeutic target in multiple sclerosis

By Rangaraju Srikant Chi Victor Pennington Michael W Chandy K George

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 8, 2009-08 ,pp. : 909-924

Informa Healthcare

Access to resources Recommend Favorite

Rosiglitazone

By Wolffenbuttel B.H. Sels J-P. Huijberts M.S.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 467-478

Informa Healthcare

Access to resources Recommend Favorite